AURA insider transactions
Aura Biosciences Inc. (AURA) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for AURA
- Officer Holles Natalie C. was granted 1,153,962 shares (SEC Form 4)4 - Aura Biosciences, Inc. (0001501796) (Issuer)
- Large owner Matrix Capital Management Company, Lp sold $39,044,987 worth of shares (6,922,870 units at $5.64) (SEC Form 4)4 - Aura Biosciences, Inc. (0001501796) (Issuer)
- SEC Form 3 filed by new insider Holles Natalie C.3 - Aura Biosciences, Inc. (0001501796) (Issuer)
- SEC Form 4 filed by Kilroy Conor4 - Aura Biosciences, Inc. (0001501796) (Issuer)
- Officer De Los Pinos Elisabet was granted 166,000 shares, increasing direct ownership by 41% to 575,815 units (SEC Form 4)4 - Aura Biosciences, Inc. (0001501796) (Issuer)
- Officer Gibney Anthony S was granted 71,245 shares, increasing direct ownership by 34% to 278,178 units (SEC Form 4)4 - Aura Biosciences, Inc. (0001501796) (Issuer)
- Officer Kilroy Conor was granted 62,339 shares, increasing direct ownership by 37% to 229,573 units (SEC Form 4)4 - Aura Biosciences, Inc. (0001501796) (Issuer)
- Chief Technology Officer Plavsic Mark was granted 62,339 shares, increasing direct ownership by 34% to 243,736 units (SEC Form 4)4 - Aura Biosciences, Inc. (0001501796) (Issuer)
- Chief Medical Officer Hopkins Janet Jill was granted 89,056 shares, increasing direct ownership by 38% to 321,340 units (SEC Form 4)4 - Aura Biosciences, Inc. (0001501796) (Issuer)
- Senior Vice President, Finance Elazzouzi Amy was granted 44,528 shares, increasing direct ownership by 59% to 120,060 units (SEC Form 4)4 - Aura Biosciences, Inc. (0001501796) (Issuer)
- Officer Kilroy Conor sold $60,999 worth of shares (12,079 units at $5.05), decreasing direct ownership by 7% to 167,234 units (SEC Form 4)4 - Aura Biosciences, Inc. (0001501796) (Issuer)
- Chief Technology Officer Plavsic Mark sold $80,244 worth of shares (15,890 units at $5.05), decreasing direct ownership by 8% to 181,397 units (SEC Form 4)4 - Aura Biosciences, Inc. (0001501796) (Issuer)
- Chief Medical Officer Hopkins Janet Jill sold $103,229 worth of shares (20,401 units at $5.06), decreasing direct ownership by 8% to 232,284 units (SEC Form 4)4 - Aura Biosciences, Inc. (0001501796) (Issuer)
- Senior Vice President, Finance Elazzouzi Amy sold $43,258 worth of shares (8,549 units at $5.06), decreasing direct ownership by 10% to 75,532 units (SEC Form 4)4 - Aura Biosciences, Inc. (0001501796) (Issuer)
- Officer De Los Pinos Elisabet sold $241,099 worth of shares (47,648 units at $5.06), decreasing direct ownership by 10% to 409,815 units (SEC Form 4)4 - Aura Biosciences, Inc. (0001501796) (Issuer)
- Senior Vice President, Finance Elazzouzi Amy sold $7,684 worth of shares (1,581 units at $4.86), decreasing direct ownership by 2% to 84,081 units (SEC Form 4)4 - Aura Biosciences, Inc. (0001501796) (Issuer)
- Officer De Los Pinos Elisabet sold $82,270 worth of shares (16,928 units at $4.86), decreasing direct ownership by 4% to 457,463 units (SEC Form 4)4 - Aura Biosciences, Inc. (0001501796) (Issuer)
- Chief Medical Officer Hopkins Janet Jill sold $92,731 worth of shares (17,109 units at $5.42), decreasing direct ownership by 6% to 252,685 units (SEC Form 4)4 - Aura Biosciences, Inc. (0001501796) (Issuer)
- Senior Vice President, Finance Elazzouzi Amy sold $5,690 worth of shares (896 units at $6.35), decreasing direct ownership by 1% to 85,662 units (SEC Form 4)4 - Aura Biosciences, Inc. (0001501796) (Issuer)
- Officer De Los Pinos Elisabet sold $57,461 worth of shares (9,049 units at $6.35), decreasing direct ownership by 2% to 474,391 units (SEC Form 4)4 - Aura Biosciences, Inc. (0001501796) (Issuer)
- Chief Technology Officer Plavsic Mark sold $77,273 worth of shares (12,169 units at $6.35), decreasing direct ownership by 6% to 197,287 units (SEC Form 4)4 - Aura Biosciences, Inc. (0001501796) (Issuer)
- Senior Vice President, Finance Elazzouzi Amy exercised 12,899 shares at a strike of $3.96 and sold $51,737 worth of shares (7,722 units at $6.70), increasing direct ownership by 6% to 86,558 units (SEC Form 4)4 - Aura Biosciences, Inc. (0001501796) (Issuer)
- Director Srivastava Sapna was granted 13,000 shares, increasing direct ownership by 124% to 23,500 units (SEC Form 4)4 - Aura Biosciences, Inc. (0001501796) (Issuer)
- Director Johnson David Michael was granted 13,000 shares, increasing direct ownership by 8% to 179,167 units (SEC Form 4)4 - Aura Biosciences, Inc. (0001501796) (Issuer)
- Director Mattessich Antony C. was granted 13,000 shares, increasing direct ownership by 124% to 23,500 units (SEC Form 4)4 - Aura Biosciences, Inc. (0001501796) (Issuer)
- Officer Gibney Anthony S was granted 150,000 shares, increasing direct ownership by 263% to 206,933 units (SEC Form 4)4 - Aura Biosciences, Inc. (0001501796) (Issuer)
- Officer De Los Pinos Elisabet exercised 10,948 shares at a strike of $5.07 and covered exercise/tax liability with 9,948 shares, increasing direct ownership by 0.21% to 483,440 units (SEC Form 4)4 - Aura Biosciences, Inc. (0001501796) (Issuer)
- Director Johnson David Michael bought $98,000 worth of shares (20,000 units at $4.90), increasing direct ownership by 14% to 166,167 units (SEC Form 4)4 - Aura Biosciences, Inc. (0001501796) (Issuer)
- Officer Gibney Anthony S bought $245,000 worth of shares (50,000 units at $4.90) and sold $7,823 worth of shares (1,519 units at $5.15), increasing direct ownership by 574% to 56,933 units (SEC Form 4)4 - Aura Biosciences, Inc. (0001501796) (Issuer)
- New insider Gibney Anthony S claimed ownership of 8,452 shares (SEC Form 3)3 - Aura Biosciences, Inc. (0001501796) (Issuer)
- Senior Vice President, Finance Elazzouzi Amy sold $4,925 worth of shares (897 units at $5.49), decreasing direct ownership by 1% to 81,381 units (SEC Form 4)4 - Aura Biosciences, Inc. (0001501796) (Issuer)
- Officer Kilroy Conor sold $39,319 worth of shares (7,162 units at $5.49), decreasing direct ownership by 4% to 179,313 units (SEC Form 4)4 - Aura Biosciences, Inc. (0001501796) (Issuer)
- Director Bitetti Teresa Marie was granted 21,000 shares (SEC Form 4)4 - Aura Biosciences, Inc. (0001501796) (Issuer)
- SEC Form 3 filed by new insider Bitetti Teresa Marie3 - Aura Biosciences, Inc. (0001501796) (Issuer)
- Chief Technology Officer Plavsic Mark sold $16,670 worth of shares (2,151 units at $7.75), decreasing direct ownership by 1% to 209,456 units (SEC Form 4)4 - Aura Biosciences, Inc. (0001501796) (Issuer)
- Senior Vice President, Finance Elazzouzi Amy sold $10,881 worth of shares (1,404 units at $7.75), decreasing direct ownership by 2% to 82,278 units (SEC Form 4)4 - Aura Biosciences, Inc. (0001501796) (Issuer)
- Chief Medical Officer Hopkins Janet Jill sold $19,638 worth of shares (2,534 units at $7.75), decreasing direct ownership by 0.93% to 269,794 units (SEC Form 4)4 - Aura Biosciences, Inc. (0001501796) (Issuer)
- Officer De Los Pinos Elisabet sold $156,796 worth of shares (20,221 units at $7.75), decreasing direct ownership by 4% to 482,440 units (SEC Form 4)4 - Aura Biosciences, Inc. (0001501796) (Issuer)
- Officer De Los Pinos Elisabet was granted 194,320 shares, increasing direct ownership by 63% to 502,661 units (SEC Form 4)4 - Aura Biosciences, Inc. (0001501796) (Issuer)
- Chief Technology Officer Plavsic Mark was granted 90,475 shares, increasing direct ownership by 75% to 211,607 units (SEC Form 4)4 - Aura Biosciences, Inc. (0001501796) (Issuer)
- Chief Medical Officer Hopkins Janet Jill was granted 120,635 shares, increasing direct ownership by 80% to 272,328 units (SEC Form 4)4 - Aura Biosciences, Inc. (0001501796) (Issuer)
- Officer Kilroy Conor was granted 90,475 shares, increasing direct ownership by 94% to 186,475 units (SEC Form 4)4 - Aura Biosciences, Inc. (0001501796) (Issuer)
- Senior Vice President, Finance Elazzouzi Amy was granted 45,240 shares, increasing direct ownership by 118% to 83,682 units (SEC Form 4)4 - Aura Biosciences, Inc. (0001501796) (Issuer)
- Officer De Los Pinos Elisabet sold $122,381 worth of shares (15,955 units at $7.67), decreasing direct ownership by 5% to 304,692 units (SEC Form 4)4 - Aura Biosciences, Inc. (0001501796) (Issuer)
- Vice President, Finance Elazzouzi Amy sold $7,679 worth of shares (1,001 units at $7.67), decreasing direct ownership by 3% to 38,442 units (SEC Form 4)4 - Aura Biosciences, Inc. (0001501796) (Issuer)
- Chief Medical Officer Hopkins Janet Jill sold $110,663 worth of shares (11,822 units at $9.36), decreasing direct ownership by 7% to 151,693 units (SEC Form 4)4 - Aura Biosciences, Inc. (0001501796) (Issuer)
- Officer De Los Pinos Elisabet sold $98,788 worth of shares (9,200 units at $10.74), decreasing direct ownership by 3% to 320,647 units (SEC Form 4)4 - Aura Biosciences, Inc. (0001501796) (Issuer)
- Vice President, Finance Elazzouzi Amy sold $5,938 worth of shares (553 units at $10.74), decreasing direct ownership by 1% to 39,443 units (SEC Form 4)4 - Aura Biosciences, Inc. (0001501796) (Issuer)
- New insider Elazzouzi Amy claimed ownership of 39,996 shares (SEC Form 3)3 - Aura Biosciences, Inc. (0001501796) (Issuer)
- Chief Financial Officer Feder Julie B exercised 25,131 shares at a strike of $3.44 and sold $302,361 worth of shares (25,131 units at $12.03) (SEC Form 4)4 - Aura Biosciences, Inc. (0001501796) (Issuer)
- Officer De Los Pinos Elisabet exercised 24,992 shares at a strike of $2.74 and sold $300,839 worth of shares (24,992 units at $12.04) (SEC Form 4)4 - Aura Biosciences, Inc. (0001501796) (Issuer)
- Chief Technology Officer Plavsic Mark sold $72,723 worth of shares (7,383 units at $9.85), decreasing direct ownership by 6% to 121,132 units (SEC Form 4)4 - Aura Biosciences, Inc. (0001501796) (Issuer)
- Officer De Los Pinos Elisabet exercised 5,474 shares at a strike of $5.76, increasing direct ownership by 2% to 329,847 units (SEC Form 4)4 - Aura Biosciences, Inc. (0001501796) (Issuer)
- Director Mattessich Antony C. was granted 10,500 shares (SEC Form 4)4 - Aura Biosciences, Inc. (0001501796) (Issuer)
- Director Srivastava Sapna was granted 10,500 shares (SEC Form 4)4 - Aura Biosciences, Inc. (0001501796) (Issuer)
- Director Johnson David Michael was granted 10,500 shares, increasing direct ownership by 8% to 146,167 units (SEC Form 4)4 - Aura Biosciences, Inc. (0001501796) (Issuer)
- Kilroy Conor was granted 96,000 shares (SEC Form 4)4 - Aura Biosciences, Inc. (0001501796) (Issuer)
- SEC Form 3 filed by new insider Kilroy Conor3 - Aura Biosciences, Inc. (0001501796) (Issuer)
- New insider Plavsic Mark claimed ownership of 128,515 shares (SEC Form 3)3 - Aura Biosciences, Inc. (0001501796) (Issuer)
- De Los Pinos Elisabet was granted 162,935 shares, increasing direct ownership by 101% to 324,373 units (SEC Form 4)4 - Aura Biosciences, Inc. (0001501796) (Issuer)